Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

514
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
514
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

483
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
483
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

594
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
594
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

377
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
377
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

403
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
403
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

441
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
441

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From underwater physiology to intensive care: oxygen tolerance unit at the bedside.

Critical care (London, England)·2026
Same author

Resilience of lung grafts to warm ischemia: assessment by <i>ex vivo</i> perfusion using functional and molecular analysis.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

AI for Radiology: A Primer Part II. Interacting with AI Results.

Radiology·2026
Same author

The association of estimated citrate load with frozen plasma versus four-factor prothrombin complex concentrate for coagulopathy after cardiac surgery: a <i>post hoc</i> exploratory analysis of the FARES-II randomised controlled trial.

BJA open·2026
Same author

Management of Shock After Cardiac Surgery.

Cardiology clinics·2026
Same author

Feasibility, Safety and Outcomes of Early Mobilization in the ICU Following Lung Transplantation: A Scoping Review.

Clinical transplantation·2026

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.4K

Frailty assessment and candidate optimization before cardiothoracic transplantation.

Antoine Premachandra1,2, Jacob Klapper3, Jonathan Messika4

  • 1Department of Anesthesiology, Foch Hospital, Suresnes, France.

JHLT Open
|February 16, 2026
PubMed
Summary

Frailty significantly impacts thoracic transplant patients with end-stage cardiopulmonary disease. Addressing frailty before heart and lung transplant can improve outcomes and reduce mortality.

Keywords:
BiomarkersCachexiaFrailtyHeart transplantationLung transplantationPrehabilitationSarcopenia

More Related Videos

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.4K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

793

Related Experiment Videos

Last Updated: Feb 17, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.4K
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.4K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

793

Area of Science:

  • Gerontology
  • Cardiology
  • Pulmonology

Background:

  • Frailty is a growing concern in aging populations undergoing thoracic transplantation.
  • End-stage cardiopulmonary disease exacerbates the lack of physiologic reserve in these patients.
  • Frailty is linked to adverse perioperative outcomes in heart and lung transplant recipients.

Purpose of the Study:

  • To review the definition and measurement of frailty in thoracic transplant candidates.
  • To explore interventions for managing frailty contributors in this population.
  • To emphasize the importance of pre-transplant frailty assessment and treatment.

Main Methods:

  • This is a review article.
  • Literature search on frailty, thoracic transplantation, and perioperative outcomes.
  • Synthesis of current evidence on frailty assessment and management.

Main Results:

  • Frailty assessment is crucial for identifying patients with diminished physiologic reserve.
  • Interventions targeting frailty can potentially improve perioperative outcomes.
  • Early identification and treatment of frailty are key to preventing complications.

Conclusions:

  • Frailty is a critical determinant of outcomes in thoracic transplant recipients.
  • Proactive management of frailty before heart and lung transplantation is essential.
  • Addressing frailty can mitigate comorbidity and mortality risks in the transplant population.